Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors
Kein-Leong YimVelindre Cancer Center, Cardiff, Wales, United KingdomAbstract: Pancreatic neuroendocrine tumors are rare and the majority of patients present in the advanced stage. Over the past few decades, treatment for patients with metastatic well- or moderately differentiated pancreatic neuroend...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-07-01
|
| Series: | Cancer Management and Research |
| Online Access: | http://www.dovepress.com/everolimus-and-mtor-inhibition-in-pancreatic-neuroendocrine-tumors-a10559 |